Horizon Kinetics Asset Management LLC Lantern Pharma Inc. Transaction History
Horizon Kinetics Asset Management LLC
- $7.14 Billion
- Q4 2024
A detailed history of Horizon Kinetics Asset Management LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 28,791 shares of LTRN stock, worth $116,891. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,791
Previous 27,582
4.38%
Holding current value
$116,891
Previous $101,000
9.9%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.48MCall Options Held
4.6KPut Options Held
600-
Bios Capital Management, LP Fort Worth, TX1.21MShares$4.9 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.48 Million0.0% of portfolio
-
Cm Management, LLC200KShares$811,9990.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.3KShares$354,4370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87KShares$353,1100.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $44M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...